| Q64079799 | Abnormal Phase Coupling in Parkinson's Disease and Normalization Effects of Subthreshold Vestibular Stimulation |
| Q36248918 | Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia. |
| Q58750796 | Assessment of Metacognition and Reversal Learning in Parkinson's Disease: Preliminary Results |
| Q39155600 | Cortical Potentials Prior to Movement in Parkinson's Disease. |
| Q26744652 | Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson's Disease: Implications for Rehabilitation |
| Q50016908 | Effectiveness of Rotigotine plus intensive and goal-based rehabilitation versus Rotigotine alone in "de-novo" Parkinsonian subjects: a randomized controlled trial with 18-month follow-up |
| Q64968139 | Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia |
| Q37516434 | Maladaptive Synaptic Plasticity in L-DOPA-Induced Dyskinesia |
| Q42696309 | Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease. |
| Q89510263 | Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease |
| Q37707226 | Reduced CA2-CA3 Hippocampal Subfield Volume Is Related to Depression and Normalized by l-DOPA in Newly Diagnosed Parkinson's Disease |
| Q42719947 | Release of chemical transmitters from cell bodies and dendrites of nerve cells |
| Q52371217 | Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities. |
| Q52150513 | The changing tree in Parkinson's disease. |
| Q38914186 | The effect of L-dopa in Parkinson's disease as revealed by neurophysiological studies of motor and sensory functions |
| Q88150069 | The missing, the short, and the long: Levodopa responses and dopamine actions |
| Q39012371 | l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role? |
Search more.